# New Trials

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/new-trials

- Industry: Healthcare IT
- Headquarters: Hangzhou, China
- Website: www.newtrials.cn
- Latest round: Series A (Feb 28, 2025)
- Investors on record: 5

## About

Founded in 2020 and based in Hangzhou, China, New Trials is a medical technology company that provides digital platforms and services in the field of clinical trials. Jiefei Jin, the founder, and CEO of the company, used to work for Pfizer and medical big data companies. As of 2022, the company has nearly 70 employees. In June 2023, New Trials raised series A funding led by new investor Eight Roads Ventures, with participation from other new investors Airui Investment and Sherpa Healthcare Partners. In February 2025, the firm raised series A+ funding from new investor Hangzhou Heda Financial Services, returning investors Sherpa Healthcare Partners, and HongShan. 

The company is engaged in providing digital platforms and services in the field of clinical trials, aiming to provide products and services for pharmaceutical enterprises, CRO companies, SMO companies, and hospitals in the clinical trials industry through big data, artificial intelligence, and other technology. The main products include CTMS (Clinical Trial Management System), GCP Pharmacy and CTRM (Clinical Trial Monitoring System), etc. 

The company's main source comes from charging clinical trial sponsors on a SaaS subscription model.

The company will use the funding to continue expanding its hospital network and accelerate the application of DeepSeek in the clinical trial industry.

## Funding rounds

- Series A, Feb 28, 2025 — HSG, Sherpa Healthcare Partners, Hangzhou Heda Financial Services
- Series A, Jun 15, 2023 — Eight Roads Ventures, Sherpa Healthcare Partners, Airui Investment

## Investors

- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series A
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series A
- Airui Investment — Series A
- HSG (https://capitalatlas.ai/funds/hsg) — Series A
- Hangzhou Heda Financial Services — Series A